• Profile
Close

Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: A multihospital cohort study

Annals of Internal Medicine Aug 09, 2019

Vaughn VM, Flanders SA, Snyder A, et al. - In this retrospective cohort study involving 6,481 general care medical patients with pneumonia, researchers investigated predictors and outcomes correlated with excess duration of antibiotic treatment (excess days per 30-day period). They found that antibiotics prescribed at discharge accounted for an excess duration of 93.2%. Each excess day of treatment was linked to a 5% increase in the odds of antibiotic-associated adverse events reported by patients after discharge. Furthermore, excess antibiotic therapy was often given to patients hospitalized with pneumonia. Patients who had respiratory or noncultural diagnostic tests, had a longer stay, got a high-risk antibiotic in the previous 90 days, had community-acquired pneumonia, or did not have a complete period of antibiotic therapy documented at release were more likely to receive surplus therapy. However, excess treatment was not linked to lower rates of any adverse outcomes, including death, readmission, emergency department visit, or Clostridioides difficile infection.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay